4.01
+0.1(+2.56%)
Currency In USD
| Previous Close | 3.91 |
| Open | 3.89 |
| Day High | 4.03 |
| Day Low | 3.87 |
| 52-Week High | 8.04 |
| 52-Week Low | 3.52 |
| Volume | 372,299 |
| Average Volume | 901,161 |
| Market Cap | 299.12M |
| PE | 26.73 |
| EPS | 0.15 |
| Moving Average 50 Days | 3.82 |
| Moving Average 200 Days | 4.3 |
| Change | 0.1 |
If you invested $1000 in OraSure Technologies, Inc. (OSUR) 10 years ago, it would be worth $483.72 as of February 05, 2025 at a share price of $4.01. Whereas If you bought $1000 worth of OraSure Technologies, Inc. (OSUR) shares 5 years ago, it would be worth $581.16 as of February 05, 2025 at a share price of $4.01.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OraSure to Present at the J.P Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2025 9:05 PM GMT
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that members of its management team will participate i
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
GlobeNewswire Inc.
Jan 07, 2025 1:50 PM GMT
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence of the release (read "OraQuick® HIV Self-Test th
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
GlobeNewswire Inc.
Jan 07, 2025 12:05 PM GMT
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick® HIV Se